Camp4 Therapeutics CSO Daniel Tardiff disposes of 1,738 common shares worth $8,272.88
Reuters2026/08/20 00:46Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Camp4 Therapeutics Chief Scientific Officer Daniel Tardiff sold 1,738 common shares on Aug. 19, 2026 at USD 4.76.
- Direct holdings fell to 0 shares following the transaction.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-058107), on August 19, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tenedora de Acciones CM to absorb EMPEI in share-swap merger
Reuters•2026/08/20 02:48
Singapore Dollar Edges Lower as Traders Weigh Treasury Dept's Buyback Announcement -- Market Talk
Dow Jones•2026/08/20 02:44
Sherritt says court declines Kyma bid to force shareholder meeting by end-September 2026
Reuters•2026/08/20 02:36
